{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:28:55Z","timestamp":1787020135564,"version":"build-2736575974"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:00:00Z","timestamp":1625529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T00:00:00Z","timestamp":1625529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Nephrol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Thrombotic microangiopathy (TMA)-mediated acute kidney injury (AKI) following massive haemorrhage is a rare but severe complication of the post-partum period. It is associated with a poor renal prognosis and a high risk of end-stage kidney disease. Complement activation may occur in this picture. However, whether complement activation, and thus complement blockade, may be critically relevant in this setting is unknown.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 50\u2009year-old woman presented with massive delayed post-partum haemorrhage (PPH). Despite bleeding control and normalization of coagulation parameters, she rapidly developed AKI stage 3 associated with dysmorphic microhematuria and proteinuria up to 2\u2009g\/day with the need of renal replacement therapy. Blood tests showed signs of TMA associated with markedly increased sC5b-9 and factor Bb plasma levels, respectively markers of terminal and alternative complement pathway over-activation. This clinical picture prompted us to initiate anti-C5 therapy. sC5b-9 normalized within 12\u2009h after the first dose of eculizumab, factor Bb and C3 after seven days, platelet count after nine days and haptoglobin after 3\u2009weeks. The clinical picture improved rapidly with blood pressure control within 48\u2009h. Diuresis resumed after three days, kidney function rapidly improved and haemodialysis could be discontinued after the sixth and last dose. Serum creatinine returned to normal two years after presentation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>We suggest that massive PPH induced major activation of complement pathways, which ultimately lead to TMA-induced AKI. Various causes, such as oocyte-donation, the potential retention of placental material and the use of tranexamic acid may have contributed to complement activation due to PPH. The prompt administration of anti-C5 therapy may have rapidly restored kidney microcirculation patency, thus reversing signs of TMA and AKI. We propose that complement activation may represent a major pathophysiological player of this complication and may provide a novel therapeutic avenue to improve renal prognosis in TMA-induced AKI following massive PPH.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12882-021-02456-1","type":"journal-article","created":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T05:03:11Z","timestamp":1625547791000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Complement activation and blockade in massive post-partum haemorrhage, thrombotic microangiopathy and acute kidney injury: a case report"],"prefix":"10.1186","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6593-8871","authenticated-orcid":false,"given":"G.","family":"Guzzo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Kissling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Pantaleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pascual","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Sadallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Teta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,6]]},"reference":[{"issue":"12","key":"2456_CR1","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.2215\/CJN.13121211","volume":"7","author":"F Fakhouri","year":"2012","unstructured":"Fakhouri F, Vercel C, Fremeaux-Bacchi V. Obstetric nephrology: AKI and thrombotic microangiopathies in pregnancy. Clin J Am Soc Nephrol. 2012;7(12):2100\u20136. https:\/\/doi.org\/10.2215\/CJN.13121211.","journal-title":"Clin J Am Soc Nephrol"},{"key":"2456_CR2","doi-asserted-by":"publisher","unstructured":"Brocklebank V, Wood KM, Kavanagh D. Thrombotic Microangiopathy and the Kidney. Clin J Am Soc Nephrol. 2018;13(2):300\u201317. https:\/\/doi.org\/10.2215\/CJN.00620117.","DOI":"10.2215\/CJN.00620117"},{"issue":"12","key":"2456_CR3","doi-asserted-by":"publisher","first-page":"3085","DOI":"10.1681\/ASN.2014100954","volume":"26","author":"AM Hildebrand","year":"2015","unstructured":"Hildebrand AM, Liu K, Shariff SZ, Ray JG, Sontrop JM, Clark WF, et al. Characteristics and outcomes of AKI treated with dialysis during pregnancy and the postpartum period. J Am Soc Nephrol. 2015;26(12):3085\u201391. https:\/\/doi.org\/10.1681\/ASN.2014100954.","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"2456_CR4","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1053\/j.ajkd.2015.11.022","volume":"68","author":"M Frimat","year":"2016","unstructured":"Frimat M, Decambron M, Lebas C, Moktefi A, Lemaitre L, Gnemmi V, et al. Renal cortical necrosis in postpartum hemorrhage: a case series. Am J Kidney Dis. 2016;68(1):50\u20137. https:\/\/doi.org\/10.1053\/j.ajkd.2015.11.022.","journal-title":"Am J Kidney Dis"},{"key":"2456_CR5","doi-asserted-by":"publisher","unstructured":"Meibody F, Jamme M, Tsatsaris V, Provot F, Lambert J, Fr\u00e9meaux-Bacchi V, et al. Post-partum acute kidney injury: sorting placental and non-placental thrombotic microangiopathies using the trajectory of biomarkers. Nephrol Dial Transplant. 2020;35(9):1538\u201346. https:\/\/doi.org\/10.1093\/ndt\/gfz025.","DOI":"10.1093\/ndt\/gfz025"},{"issue":"2","key":"2456_CR6","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1152\/jappl.2001.90.2.441","volume":"90","author":"JG Younger","year":"2001","unstructured":"Younger JG, Sasaki N, Waite MD, et al. Detrimental effects of complement activation in hemorragic shock. J Appl Physiol (1985). 2001;90(2):441\u20136. https:\/\/doi.org\/10.1152\/jappl.2001.90.2.441.","journal-title":"J Appl Physiol (1985)"},{"issue":"4","key":"2456_CR7","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1097\/01.shk.0000082444.66379.17","volume":"20","author":"J Szebeni","year":"2003","unstructured":"Szebeni J, Baranyi L, Savay S, et al. Complement activation during hemorrhagic shock and resuscitation in swine. Shock. 2003;20(4):347\u201355. https:\/\/doi.org\/10.1097\/01.shk.0000082444.66379.17.","journal-title":"Shock."},{"issue":"2","key":"2456_CR8","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1152\/japplphysiol.00917.2006","volume":"102","author":"RM Peckham","year":"2007","unstructured":"Peckham RM, Handrigan MT, Bentley TB, et al. C5-blocking antibody reduces requirements and improves responsiveness to fluid infusion in hemorrhagic shock managed with hypotensive resuscitation. J Appl Physiol (1985). 2007;102(2):673\u201380. https:\/\/doi.org\/10.1152\/japplphysiol.00917.2006.","journal-title":"J Appl Physiol (1985)"},{"issue":"1","key":"2456_CR9","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/shk.0b013e3180342439","volume":"28","author":"MT Ganter","year":"2007","unstructured":"Ganter MT, Brohi K, Cohen MJ, Shaffer LA, Walsh MC, Stahl GL, et al. Role of the alternative pathway in the early complement activation following major trauma. Shock. 2007;28(1):29\u201334. https:\/\/doi.org\/10.1097\/shk.0b013e3180342439.","journal-title":"Shock."},{"key":"2456_CR10","doi-asserted-by":"publisher","first-page":"215","DOI":"10.3389\/fimmu.2015.00215","volume":"6","author":"HI Kenawy","year":"2015","unstructured":"Kenawy HI, Boral I, Bevington A. Complement-coagulation cross-talk: a potential mediator of the physiological activation of complement by low pH. Front Immunol. 2015;6:215. https:\/\/doi.org\/10.3389\/fimmu.2015.00215.","journal-title":"Front Immunol"},{"key":"2456_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/978-0-387-78952-1_6","volume":"632","author":"U Amara","year":"2008","unstructured":"Amara U, Rittirsch D, Flierl M, et al. Interaction between the coagulation and complement system. Adv Exp Med Biol. 2008;632:71\u20139. https:\/\/doi.org\/10.1007\/978-0-387-78952-1_6.","journal-title":"Adv Exp Med Biol"},{"issue":"6","key":"2456_CR12","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1038\/nm1419","volume":"12","author":"M Huber-Lang","year":"2006","unstructured":"Huber-Lang M, Sarma JV, Zetoune FS, Rittirsch D, Neff TA, McGuire SR, et al. Generation of C5a in the absence of C3: a new complement activation pathway. Nat Med. 2006;12(6):682\u20137. https:\/\/doi.org\/10.1038\/nm1419.","journal-title":"Nat Med"},{"issue":"9","key":"2456_CR13","doi-asserted-by":"publisher","first-page":"5628","DOI":"10.4049\/jimmunol.0903678","volume":"185","author":"U Amara","year":"2010","unstructured":"Amara U, Flierl MA, Rittirsch D, Klos A, Chen H, Acker B, et al. Molecular intercommunication between the complement and coagulation systems. J Immunol. 2010;185(9):5628\u201336. https:\/\/doi.org\/10.4049\/jimmunol.0903678.","journal-title":"J Immunol"},{"issue":"3","key":"2456_CR14","first-page":"587","volume":"45","author":"RG DiScipio","year":"1982","unstructured":"DiScipio RG. The activation of the alternative pathway C3 convertase by human plasma kallikrein. Immunology. 1982;45(3):587\u201395 PMID: 6916710; PMCID: PMC1555245.","journal-title":"Immunology"},{"issue":"6","key":"2456_CR15","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1515\/jpm.2010.084","volume":"38","author":"A Shrim","year":"2010","unstructured":"Shrim A, Levin I, Mallozzi A, Brown R, Salama K, Gamzu R, et al. Does very advanced maternal age, with or without egg donation, really increase obstetric risk in a large tertiary center? J Perinat Med. 2010;38(6):645\u201350. https:\/\/doi.org\/10.1515\/jpm.2010.084.","journal-title":"J Perinat Med"},{"issue":"9734","key":"2456_CR16","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","volume":"376","author":"H Shakur","year":"2010","unstructured":"CRASH-2 trial collaborators, Shakur H, Roberts I, Bautista R, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376(9734):23\u201332. https:\/\/doi.org\/10.1016\/S0140-6736(10)60835-5.","journal-title":"Lancet"},{"key":"2456_CR17","volume-title":"WHO recommendations for the prevention and treatment of postpartum haemorrhage","author":"WHO","year":"2012","unstructured":"WHO. WHO recommendations for the prevention and treatment of postpartum haemorrhage. Geneva: World Health Organization; 2012."}],"container-title":["BMC Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02456-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12882-021-02456-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12882-021-02456-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,6]],"date-time":"2021-07-06T05:14:58Z","timestamp":1625548498000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcnephrol.biomedcentral.com\/articles\/10.1186\/s12882-021-02456-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,6]]},"references-count":17,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["2456"],"URL":"https:\/\/doi.org\/10.1186\/s12882-021-02456-1","relation":{},"ISSN":["1471-2369"],"issn-type":[{"value":"1471-2369","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,6]]},"assertion":[{"value":"17 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable to case reporting. We did not conduct an experimental study. We described and reported the clinical management of this special case.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The patient has been informed. The consent for publication has been signed from the patient (March 6, 2021).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"252"}}